1 材料与方法
1.1 数据库及软件
表1 主要数据库及软件Table 1 Main databases and softwares |
| 名称 Name | 网址 URL |
|---|---|
| 数据库 Databases | |
| 中药系统药理学数据库 TCMSP database | https://tcmsp-e.com/tcmsp.php |
| PubChem数据库 PubChem datebase | https://pubchem.ncbi.nlm.nih.gov |
| SwissTargetPrediction数据库 SwissTargetPrediction database | http://www.swisstargetprediction.ch |
| TargetNet数据库 TargetNet database | http://targetnet.scbdd.com |
| SuperPred数据库 SuperPred database | http://prediction.charite.de |
| PharmMapper数据库 PharmMapper database | https://www.lilab-ecust.cn/pharmmapper |
| Uniprot数据库 Uniprot database | https://www.uniprot.org |
| GeneCards数据库 GeneCards database | https://www.genecards.org |
| 微生信云平台 Weishengxinyun platform | https://www.bioinformatics.com.cn |
| STRING平台数据库 STRING database | https://string-db.org |
| DAVID数据库 DAVID database | https://david.ncifcrf.gov |
| GenBank数据库 GenBank database | https://www.ncbi.nlm.nih.gov |
| PDB数据库 PDB database | https://www.rcsb.org |
| 软件 Softwares | |
| Cytoscape 3.8.0 | https://cytoscape.org |
| AutoDock Vina 1.2.5 | https://vina.scripps.edu |
| Pymol 2.6 | https://pymol.org |
| GraphPad Prism 9.0 | https://www.graphpad.com |
1.2 芦丁作用靶点预测
1.3 肠道损伤相关靶点预测
1.4 芦丁作用靶点与肠道损伤相关靶点交集分析
1.5 蛋白质-蛋白质相互作用(PPI)网络构建
1.6 芦丁缓解猪肠道损伤的核心靶点筛选
1.7 基因本体(GO)功能和京都基因与基因组百科全书数据库(KEGG)通路富集分析
1.8 芦丁-肠道损伤靶点-信号通路网络构建
1.9 分子对接验证
1.10 体外细胞试验验证
1.10.1 猪小肠上皮细胞系(IPEC-J2)细胞培养
1.10.2 RNA提取
1.10.3 反转录
1.10.4 引物设计
表2 RT-qPCR引物序列Table 2 Primer sequences for RT-qPCR |
| 基因名称 Gene names | 引物序列 Primer sequences (5'—3') | 产物长度 Product length/bp | 登录号 Accession number |
|---|---|---|---|
| 甘油醛-3-磷酸脱氢酶 GAPDH | F:TCGGAGTGAACGGATTTGGC R:TGCCGTGGGTGGAATCATAC | 147 | NM_001206359.1 |
| 胰岛素 INS | F:TTCTTCTACACGCCCAAGGC R:TTATTGGGTTTTGGGGTGCG | 234 | NM_001109772.2 |
| 热休克蛋白90αA1 HSP90AA1 | F:GGAGAAGAAAGTCGAAAAGGTGG R:AGAGGGAATGCAGACAGCGT | 516 | NM_213973.2 |
| 缺氧诱导因子1α HIF1A | F:TCAAGCAGTAGGAATTGGAACA R:AGAACCGTGAATGTGCTGTC | 511 | NM_001123124.1 |
| Toll样受体4 TLR4 | F:TGGATTTATCCAGCCAGGACG R:CAGTCCTGTGTATCTCGGGC | 622 | NM_001293317.1 |
| 雌激素受体1 ESR1 | F:GCAAAGAGGGTGCCAGGATT R:GTGCGACAGGGATTCTTGGA | 755 | XM_021083075.1 |
1.10.5 RT-qPCR
1.11 数据统计与分析
2 结果与分析
2.1 芦丁的作用靶点和肠道损伤相关靶点预测
2.2 芦丁作用靶点与肠道损伤相关靶点交集分析
2.3 PPI网络图构建
图3 芦丁缓解猪肠道损伤的PPI网络图仅注释图中关键节点 annotate only the key nodes in the diagram。HSP90AA1:热休克蛋白90αA1 heat shock protein 90 alpha family class a member 1;HIF1A:缺氧诱导因子1α hypoxia inducible factor 1 subunit alpha;INS:胰岛素 insulin;TLR4:Toll样受体4 Toll like receptor 4;ESR1:雌激素受体1 estrogen receptor 1;CXCR4:CXC趋化因子受体4 c-x-c motif chemokine receptor 4;PTGS2:前列腺素内过氧化物合酶2 prostaglandin-endoperoxide synthase 2;NFKB1:核因子κB亚基1 nuclear factor kappa B subunit 1;MAPK1:丝裂原活化蛋白激酶1 mitogen-activated protein kinase 1;IL2:白细胞介素2 interleukin 2;KDR:血管内皮生长因子受体2 kinase insert domain receptor 2;PIK3R1:磷脂酰肌醇3激酶调节亚基1 phosphoinositide-3-kinase regulatory subunit 1;CD38:分化抗原38 cluster of differentiation 38;HDAC2:组蛋白去乙酰化酶2 histone deacetylase 2;SERPINE1:丝氨酸蛋白酶抑制剂E1 serine protease inhibitor E1;MME:中性内肽酶 membrane metalloendopeptidase;PLK1:极性样激酶1 polo like kinase 1;XDH:黄嘌呤脱氢酶 xanthine dehydrogenase;GSR:谷胱甘肽还原酶 glutathione-disulfide reductase;MTOR:雷帕霉素靶蛋白 mechanistic target of rapamycin;Nrf2:核因子E2相关因子2 nuclear factor E2-related factor 2;ANPEP:氨肽酶N alanyl aminopeptidase, membrane;NOX4:NADPH氧化酶4 NADPH oxidase 4;CD28:分化抗原28 cluster of differentiation 28;ABCG2:ATP结合盒转运蛋白G2 ATP binding cassette subfamily g member 2;TERT:端粒酶逆转录酶 telomerase reverse transcriptase;FLT3:Fms样酪氨酸激酶3 fms related receptor tyrosine kinase 3;ITGB1:整合素β1 integrin subunit beta 1;CDK2:细胞周期蛋白依赖性激酶2 cyclin dependent kinase 2;CHUK:核因子-κB抑制蛋白激酶α nuclear factor-kappa B inhibitor protein kinase alpha;MAPK14:丝裂原活化蛋白激酶14 mitogen-activated protein kinase 14;PSMB1:蛋白酶体β亚基1 proteasome 20s subunit beta 1;CAT:过氧化氢酶 catalase;DMT1:二价金属转运蛋白1 divalent metal transporter 1。图4和图7同 the same as Fig.4 and Fig.7。 Fig.3 PPI network diagram of rutin alleviating porcine intestinal damage in pigs |
2.4 芦丁缓解猪肠道损伤核心靶点筛选
2.5 GO功能富集分析
图5 GO功能富集分析regulation of primary metabolic process:初级代谢过程调控;regulation of macromolecule metabolic process:大分子代谢过程调控;positive regulation of intracellular signal transduction:细胞内信号转导的正调控;activation of innate immune response:先天免疫反应激活;inflammatory response:炎症反应;regulation of gene expression:基因表达调控;one-carbon metabolic process:单碳代谢过程;innate immune response:先天免疫反应;signal transduction:信号转导;positive regulation of transcription by RNA polymerase Ⅱ:聚合酶Ⅱ介导转录的正调控;lysosome:溶酶体;phagocytic vesicle:吞噬小泡;endosome:内体;cytoplasm:细胞质;cytosol:细胞质基质;membrane raft:膜筏;endoplasmic reticulum membrane:内质网膜;cell surface:细胞表面;dendrite:树突;chromatin:染色质;carbonate dehydratase activity:碳酸酐酶活性;zinc ion binding:锌离子结合;nuclear receptor activity:核受体活性;interleukin-2 receptor binding:白细胞介素-2受体结合;protein homodimerization activity:蛋白质同源二聚化活性;estrogen response element binding:雌激素反应元件结合;oxidoreductase activity:氧化还原酶活性;protein heterodimerization activity:蛋白质异源二聚化活性;metal ion binding:金属离子结合;identical protein binding:相同蛋白质结合。 Fig.5 GO functional enrichment analysis |
2.6 KEGG通路富集分析
图6 KEGG通路富集分析Nitrogen metabolism:氮代谢;Metabolic pathways:代谢通路;HIF-1 signaling pathway:HIF-1信号通路;Insulin resistance:胰岛素抵抗;Progesterone-mediated oocyte maturation:孕激素介导的卵母细胞成熟;PD-L1 expression and PD-1 checkpoint pathway in cancer:癌症中的PD-L1表达及PD-1免疫检查点通路;Regulation of lipolysis in adipocytes:脂肪细胞中脂解的调控;Alzheimer disease:阿尔茨海默病;Fluid shear stress and atherosclerosis:流体剪切力与动脉粥样硬化;Central carbon metabolism in cancer:癌症中的中心碳代谢;Pathways in cancer:癌症通路;Prostate cancer:前列腺癌;C-type lectin receptor signaling pathway:C型凝集素受体信号通路;Chagas disease:查加斯病;Acute myeloid leukemia:急性髓系白血病;Adipocytokine signaling pathway:脂肪细胞因子信号通路;Glucagon signaling pathway:胰高血糖素信号通路;Apoptosis:细胞凋亡;Insulin signaling pathway:胰岛素信号通路;Toxoplasmosis:弓形虫病。 Fig.6 KEGG pathway enrichment analysis |
2.7 芦丁-肠道损伤靶点-信号通路网络构建
图7 芦丁-肠道损伤靶点-信号通路网络模型Rutin:芦丁;Intestinal damage:肠道损伤。 Fig.7 Rutin-intestinal damage targets-signaling pathway network model |
表3 KEGG通路名称对照表Table 3 KEGG pathway name reference table |
| 编号 ID | 描述 Description | 编号 ID | 描述 Description | |
|---|---|---|---|---|
| ssc00910 | 氮代谢 Nitrogen metabolism | ssc05200 | 癌症通路 Pathways in cancer | |
| ssc01100 | 代谢通路 Metabolic pathways | ssc05215 | 前列腺癌 Prostate cancer | |
| ssc04066 | HIF-1信号通路 HIF-1 signaling pathway | ssc04625 | C型凝集素受体信号通路 C-type lectin receptor signaling pathway | |
| ssc04931 | 胰岛素抵抗 Insulin resistance | ssc05142 | 查加斯病 Chagas disease | |
| ssc04914 | 孕激素介导的卵母细胞成熟 Progesterone-mediated oocyte maturation | ssc05221 | 急性髓系白血病 Acute myeloid leukemia | |
| ssc05235 | 癌症中的PD-L1表达及PD-1 免疫检查点通路 PD-L1 expression and PD-1 checkpoint pathway in cancer | ssc04920 | 脂肪细胞因子信号通路 Adipocytokine signaling pathway | |
| ssc04923 | 脂肪细胞中脂解的调控 Regulation of lipolysis in adipocytes | ssc04922 | 胰高血糖素信号通路 Glucagon signaling pathway | |
| ssc05010 | 阿尔茨海默病 Alzheimer disease | ssc04210 | 细胞凋亡 Apoptosis | |
| ssc05418 | 流体剪切力与动脉粥样硬化 Fluid shear stress and atherosclerosis | ssc04910 | 胰岛素信号通路 Insulin signaling pathway | |
| ssc05230 | 癌症中的中心碳代谢 Central carbon metabolism in cancer | ssc05145 | 弓形虫病 Toxoplasmosis |
2.8 分子对接验证结果
图8 芦丁与核心靶点的分子对接模型INS-Rutin:胰岛素-芦丁 insulin-rutin;HSP90AA1-Rutin:热休克蛋白90αA1-芦丁 heat shock protein 90 alpha family class A member 1-rutin;HIF1A-Rutin:缺氧诱导因子1α-芦丁 hypoxia inducible factor 1 alpha-rutin;TLR4-Rutin:Toll样受体4-芦丁 Toll like receptor 4-rutin;ESR1-Rutin:雌激素受体1-芦丁 estrogen receptor 1-rutin。 Fig.8 Molecular docking models of rutin with core targets |
表4 芦丁与各核心靶点的结合能Table 4 Binding energies between rutin and each core target |
| 核心靶点 Core targets | 结合能 Binding energy/(kJ/mol) |
|---|---|
| Toll样受体4 TLR4 | -38.07 |
| 热休克蛋白90αA1 HSP90AA1 | -34.73 |
| 雌激素受体1 ESR1 | -33.47 |
| 缺氧诱导因子1α HIF1A | -32.22 |
| 胰岛素 INS | -22.59 |

京公网安备 11010802041926号